Utilized for rheumatoid arthritis and lupus to manage autoimmune symptoms and support joint health.
Mechanism of Action
The precise mechanism in autoimmune disease is unknown, but it likely inhibits immune cell activity by interfering with antigen processing and suppressing the production of inflammatory cytokines.
Route of Administration
Oral
Onset Time
4–12 weeks
Duration
Weeks to months
Contraindications
Hypersensitivity to 4-aminoquinolines, Retinal or visual field changes
Severe Adverse Events
Retinopathy, Cardiac arrhythmias, Myelosuppression — requires immediate medical attention
Information related to Plaquenil is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
